Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 5
1989 1
1997 2
1998 2
1999 3
2000 3
2001 2
2002 5
2003 6
2004 7
2005 12
2006 3
2007 9
2008 3
2009 4
2010 5
2011 1
2012 8
2013 10
2014 8
2015 10
2016 3
2017 7
2018 5
2019 3
2020 3
2021 8
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Results by year
Filters applied: . Clear all
Page 1
Hydroxychloroquine for Primary Progressive Multiple Sclerosis.
Koch MW, Kaur S, Sage K, Kim J, Levesque-Roy M, Cerchiaro G, Yong VW, Cutter GR, Metz LM. Koch MW, et al. Among authors: metz lm. Ann Neurol. 2021 Dec;90(6):940-948. doi: 10.1002/ana.26239. Epub 2021 Oct 15. Ann Neurol. 2021. PMID: 34590328 Clinical Trial.
Prolactin in multiple sclerosis.
Zhornitsky S, Yong VW, Weiss S, Metz LM. Zhornitsky S, et al. Among authors: metz lm. Mult Scler. 2013 Jan;19(1):15-23. doi: 10.1177/1352458512458555. Epub 2012 Aug 29. Mult Scler. 2013. PMID: 22933621 Review.
Depression in multiple sclerosis.
Patten SB, Metz LM. Patten SB, et al. Among authors: metz lm. Psychother Psychosom. 1997;66(6):286-92. doi: 10.1159/000289150. Psychother Psychosom. 1997. PMID: 9403917 Review.
The promise of minocycline in neurology.
Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM. Yong VW, et al. Among authors: metz lm. Lancet Neurol. 2004 Dec;3(12):744-51. doi: 10.1016/S1474-4422(04)00937-8. Lancet Neurol. 2004. PMID: 15556807 Review.
Cannabinoids and bladder symptoms in multiple sclerosis.
Kim-Fine S, Greenfield J, Chaput KH, Robert M, Metz LM. Kim-Fine S, et al. Among authors: metz lm. Mult Scler Relat Disord. 2021 Sep;54:103105. doi: 10.1016/j.msard.2021.103105. Epub 2021 Jun 23. Mult Scler Relat Disord. 2021. PMID: 34216995
Epigenetic changes in patients with multiple sclerosis.
Koch MW, Metz LM, Kovalchuk O. Koch MW, et al. Among authors: metz lm. Nat Rev Neurol. 2013 Jan;9(1):35-43. doi: 10.1038/nrneurol.2012.226. Epub 2012 Nov 20. Nat Rev Neurol. 2013. PMID: 23165337 Review.
Symptomatic therapies of multiple sclerosis.
Metz LM, Patten SB, McGowan D. Metz LM, et al. Biomed Pharmacother. 1999 Sep;53(8):371-9. doi: 10.1016/s0753-3322(99)80108-5. Biomed Pharmacother. 1999. PMID: 10554671 Review.
129 results